The next revolution in sports viewing is not a new rulebook or a streaming app, it is a camera that seems to float through ...

Brighton-based landscape architect Patrick Clarke has unveiled an update on the resilient planting scheme for ‘The Children’s Society Garden.' ...

According to TipRanks.com, Zhu is a 5-star analyst with an average return of 14.4% and a 42.1% success rate. Zhu covers the Healthcare sector, focusing on stocks such as NewAmsterdam Pharma Company, ...

Detailed price information for Iovance Biotherapeutics Inc (IOVA-Q) from The Globe and Mail including charting and trades.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Biotechnology industry for Wednesday, January 14, 2026. Let’s ...

Arcturus Therapeutics Holdings (ARCT) is set to present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, ...

State of Electronics] have released their latest video about ARCTURUS, the 14th video in their series The Computer History of ...

CEO and President Joe Payne outlined the company’s current focus on messenger RNA (mRNA) therapeutics, emphasizing a leaner ...

In late 2025, Arcturus Therapeutics Holdings Inc. filed an omnibus shelf registration of up to US$500 million, covering ...

Payne indicated that the company intends to "evaluate daily dosing of ARCT-032 over a 12-week duration in up to 20 CF participants," with this study planned to begin in the first half of 2026. He ...

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease ...